International Biotechnology and Pharmaceutical Industry Forum

Meet the expert advisors and Keynote Speakers

Dr. G. P. Talwar

National Institute of Immunology, India

Dr. G. P. Talwar is a medical researcher working in the area of  vaccines and immunocontraception. He received BSc (Hons) and MSc (Tech) degrees from the University of Punjab, DSc from Sorbonne working at the Institut Pasteur, Paris and DSc (hc) from Bundhelkhand University.

Read more >

Dr. Anthony J.Clarke

University of Guelph, Canada

Dr. Anthony J.Clarke obtained his Ph.D from the University of Waterloo in Chemistry in 1983. He joined the University of Guelph in 1986 as an assistant professor after post-doctoral stints at the Carlsberg Research Centre, Copenhagen and the National Research Council, Ottawa.

Read more >

Bindu Ajit

Program Director, Biocon Academy

Bindu Ajit is the Program Director and Head of Biocon Academy and is responsible for the overall operations and management of Biocon Academy. She manages all partners, faculty and internal stakeholders

Read more >

Dr. S. V. Eswaran

RCB, Faridabad, India

Dr. S. V. Eswaran currently working as an emeritus scientist & emeritus professor in the regional center for biotechnology, Faridabad, India. He has received many honors and awards such as Dr. A.P.J Abdul Kalam life time achievement award 2016, The Society of biomedical laboratory scientists, India

Read more >

International Biotechnology and Pharmaceutical Industry Forum will be held on 09 to 10 October 2017 in New Delhi, India with the theme "Discussing challenges in biotechnology and pharmaceutical industry". This forum is hosted and organized by Clyto Access, where we intend to provide you an international platform for an exchange of information related to life science, biotechnology, and pharmaceutical industry. Biopharma 2017 conference is providing an extended platform to discuss challenges and advancements in biotechnology and pharma sectors.


• Pharma Vision 2020 - Opportunities and challenges
• Role of Biosimilars in Indian pharma industry.
• India’s vaccine R&D outlook: Opportunities and challenges
• Automation in pharma and biotech industry
• Best practices in scale up, scale down and technology transfer
• Personalized medicine in India
• How can regulatory bodies and pharma work closer together to establish a robust regulation framework?
• Clinical trials and approvals in India
• Ensuring uniformity of GMP inspections in biologics manufacturing
• Resolving the regulatory compliance issues in India
• Optimizing bioanalytical techniques and methods used for stability testing
• Recent developments in the genetic engineering and genetically modified products.
• Technological advancements of organs on-a-chip tools for drug discovery and study of diseases.
• Share information on technological and operational advances in the production of biofuels and other bioproducts.
• Emerging business models in the pharmaceutical industries.
• Emerging Research and clinical development trends of nanoparticle drug delivery systems.

Related Topics

Recent developments in biotechnology, Genetic Engineering, Biological warfare and bioweapons, rDNA technology and bioconjugate technology, Biomolecules and metabolism, Bioinformatics and systems biology, Bioseparation and bioprocessing, Product Design and Engineering, Enzymology and enzyme engineering, Hazard Assessment and Mitigation in Bioprocess Industries, Mass Transfer and unit operations, Animal cell culture and Transgenic Animals, Bioethics in Animal Genetic Engineering, Plant breeding & genetics, Evolution in botany, Vaccines and diagnostics, Molecular Imprinting in Biomedical Engineering, Micro RNA Profiling in Gene Expression, Food processing and brewing technology, Global food safety, security and supply chain management, Bioremediation, Biomining and Bioleaching, Sports and Continuum biomechanics, Astrobiophysics, Biotribology, , Epidemiological studies, Drugs and Pharmaceutical Technology, Clinical trials and Research, Clinical Pharmacology & Clinical Toxicology, Pharmaceutical Production Management and Packaging Technology, Pharmaceutical Marketing, Current Health Scenario in India, Quality Standards and Processes, Pharmaco-dynamics and Pharmaco-kinetics, Intellectual Property Rights, Future Business Strategies, Economic Risks and Benefits.
Abstract submission deadline (1st round)
30 June 2017
Notification of acceptance or rejection of abstract
03-10 working days from the date of submission
Final presentation should be submitted
15 days before the conference date
Early bird registration
30 April 2017


The exploitation of biological processes for industrial and other purposes, especially the genetic manipulation of microorganisms for the production of antibiotics, hormones, etc.

Track 1-1: Agricultural Biotechnology

Track 1-2: Bioanalytical techniques

Track 1-3: Nano-biotechnology

Track 1-4: Biological warfare and bioweapons

Track 1-5: Cell ageing and biotechnology

Track 1-6: Biomimetics and bioinspiration

Track 1-7: Infectious diseases and biotechnology

The branch of biology that deals with the structure and function of macromolecules (e.g. proteins and nucleic acids)which are essential to life.

Track 2-1: Genomics and Proteomics

Track 2-2: Genetic Engineering and tissue engineering

Track 2-3: Molecular Biology and synthetic biology

Track 2-4: Bioinformatics and systems biology

Track 2-5: Biomolecules and metabolism

Track 2-6: Bioenergetics and photosynthesis

Track 2-7: rDNA technology and bioconjugate technology

Track 2-8: Human and microbes physiology

Track 2-9: Protein Engineering and industrial Applications

Track 2-10: Ecological, evolutionary and comparative Physiology

A Set of practices where by using living cells (such as bacteria, yeast, algae) or component of cells like enzymes, to generate industrial products and processes.

Track 3-1: Bio thermodynamics

Track 3-2: Mass Transfer and unit operations

Track 3-3: Bioseparation and bioprocessing

Track 3-4: Downstream and upstream processing

Track 3-5: Hazard Assessment and Mitigation in Bioprocess Industries

Track 3-6: Enzyme Technology and Biotransformation

Track 3-7: Fluid Mechanics and Fluidization Engineering

Track 3-8: Bioreactor engineering and instrumental analysis

Track 3-9: Scale-up/scale down and optimization

Track 3-10: Biomolecular Engineering

Track 3-11: Product Design and Engineering

Track 3-12: Novel Approaches in Multifunctional Reaction Processes

Track 3-13: Metabolic Engineering

Track 3-14: Enzymology and enzyme engineering

Molecular biology techniques which provides new tools for developing human health and animal welfare (i.e. modify the genome of) animals in order to improve their suitability and impact on the environment.

Track 4-1: Animal cell culture and Transgenic Animals

Track 4-2: Animal Husbandry

Track 4-3: Cloning

Track 4-4: Animal welfare

Track 4-5: Bioethics in Animal Genetic Engineering

An Introduction of an advantageous trait into plants and to improve their adaptation for specific purposes through genetic modification.

Track 5-1: Plant physiology

Track 5-2: Plant breeding & genetics

Track 5-3: Pesticides

Track 5-4: Evolution in botany

Track 5-5: Botanical communication

Track 5-6: Parasitology

Track 5-7: Agricultural and horticultural sciences

 Biomedical engineering (BME) is the application of engineering principles and design concepts to medicine and biology for healthcare purposes (e.g. diagnostic or therapeutic). To decrease the human morbidity and transience, fetching the solutions for different health problems by using living cells and their materials

Track 6-1: Diagnostic Tests And Medical Devices

Track 6-2: Human immune system and disease

Track 6-3: Human genetics and genome analysis

Track 6-4: Vaccines and diagnostics

Track 6-5: Stem cell research and regenerative medicine

Track 6-6: Human genetics and genome analysis

Track 6-7: Immuno Therapeutics

Track 6-8: Biosensors and Bioelectronics

Track 6-9: Molecular Imprinting in Biomedical Engineering

Track 6-10: Electron Transfer through Proteins

Track 6-11: Chemical Sensors & Live Imaging

Track 6-12: Recent Advances of Biochips in Genomics & Protein Function

Track 6-13: Micro RNA Profiling in Gene Expression

Track 6-14: Mechanotransduction in Vascular Physiology and Atherogenesis

The study of balanced diet in order to improve health well being through food processing techniques.

Track 7-1: Food processing and preservation

Track 7-2: Health And Wellbeing Through Diet

Track 7-3: Global food safety, security and supply chain management

Track 7-4: Food processing and brewing technology

Track 7-5: Nutraceuticals and dietary supplements

The study of microbes and development of techniques for the microbial treatment, prevention of infectious disease and monitoring and controlling environmental engineering system.

Track 8-1: Improving Biodiversity In A Farmed Landscape

Track 8-2: Disease Management

Track 8-3: Bioremediation

Track 8-4: More Effective Pest Control

Track 8-5: Sustainable Liquid Fuel Production

Track 8-6: Biomining and Bioleaching

The application of biomedical techniques, integrating the engineering disciplines to analyze the dynamics of human system and properties of biological tissue.

Track 9-1: Sports and Continuum biomechanics

Track 9-2: Biofluid and Computational mechanics

Track 9-3: Biotribology

Track 9-4: Comparative biomechanics

Track 9-5: Plant biomechanics

Track 9-6: Agrophysics

Track 9-7: Biophysical chemistry and environment

Track 9-8: Biogeophysics

Track9-9: Biomineralization

Track 9-10: Astrobiophysics

Track 9-11: Cellular,Molecular and Medical biophysics

Act on diagnosis and treatment of disease through biomedical or behavioral research studies on human participants by trailing drugs on human participants.

Track 10-1: Clinical pathology

Track 10-2: Drug Evaluation

Track 10-3: Clinical trials and Research

Track 10-4: Drug Metabolism, Administration And Bioavailability

Track 10-5: Drug Regulatory, Quality and Safety evaluation

Track 10-6: Drugs and Pharmaceutical Technology

The branch of medicine concerned with the uses, effects, and modes of action of drugs.

Track 11-1: Pharmaco-dynamics and Pharmaco-kinetics

Track 11-2: Pharmaceutical Production Management and Packaging Technology

Track 11-3: Epidemiological studies

Track 11-4: Pharmacogenomics, molecular modeling & drug design

Track 11-5: Safety and Risk Management (Guidelines of GMP and GCP)

Track 11-6: Statistics of pharmaceutical industry

Track 11-7: Phytotherapy

Track 11-8: Biodrugs and cosmetics

Track 11-9: Simulation in Drug Development

Track 11-10: Clinical Pharmacology & Clinical Toxicology

Track 11-11: Biomedicinal Aspects in Pharmaceutical Biotechnology

Understanding mechanisms and processes at the genetic and molecular levels to create or improve the industrial processes and to produce economic product to society.

Track 12-1: Biotechnology Accelerators

Track 12-2: Bio-law and Bio-ethic

Track 12-3: Biopolicy and Bioeducation

Track 12-4: Biosafety and Bioethics

Track 12-5: Intellectual Property Rights

Track 12-6: Regulatory Issues in Biotechnology

Track 12-7: Economic Risks and Benefits

Track 12-8: Future Business Strategies

Track 13- 1: Stoichiometry

Track 13- 2: Material Handling systems

Track 13- 3: Filtration and Centrifugation

Track 13- 4: Crystallization and Humidification

Track 13- 5: Distillation and Drying

Track 13- 6: Pharmaceutical Marketing

Track 13- 7: Competitive Practices in Pharmaceutical Industries

Track 13- 8: Promotions, Distribution and Management

Track 13- 9: Current Health Scenario in India

Track 14 -1: Testing

Track 14 -2: Inspection

Track 14 -3: Checkpoint Review

Track 14 -4: Quality Audit

Track 14 -5: Tool Identification and Selection

Track 14 -6: Quality Standards and Processes

Track 15 -1: Design of Dosage Regimens

Track 15 -2: Pharmacokinetics of Drug Interaction

Track 15 -3: Therapeutic Drug Monitoring

Track 15 -4: Population Pharmacokinetics

Track 15 -5: Pharmacogenetics

What is Biopharma 2017?

Biotechnology provides breakthrough technologies to combat debilitating and rare diseases, reduce our environmental footprint, feed the hungry and encourage safer, cleaner and more efficient industrial manufacturing processes. At the same time, the pharmaceutical industry is also working to utilize the advanced pharmaceutical information and technology to help prevention of disease, improve health, and save lives. The forum is an excellent opportunity for the industries to present their contribution to this common goal.

Who can attend Biopharma 2017?

Biopharma-2017 is for experts like Biotechnologists, Biochemists, Pharmacists, Microbiologists, Drug developers, Doctors, Immunologists, Industrialists, Professors, Scientists, Research Associates, Pharmacologists, Quality Analysts, Chemical engineers, Bio- Mechanical Engineers, Marine engineers, Bioanalysts, Biostatistician, Food technologists, Animal welfare professionals, Bioinformaticians, Chemists, Physicians, Agriculturalists, Product developers, Healthcare Marketing experts and all faculty from universities/ institutes.

Why to attend Biopharma 2017?

Biopharma-2017, the multi-disciplinary conference aims to provide a challenging forum and vibrant opportunity for researchers and industry practitioners to share their original research and practical development experiences on specific new challenges, emerging issues and future trends in Biotechnology, Bio Engineering, Biosensors, pharmacology, genetic engineering, clinical research, pharmaceutical industries and related areas.


The global biotechnology market size was valued at USD 270.5 billion in 2013 and is expected to grow at a CAGR of 12.3% owing to the increasing demand for diagnostics and therapeutic solutions such as recombinant technology, red biotechnology, and DNA sequencing. The increasing prevalence of diseases such as cancer, hepatitis B, and other orphan disorders is expected to serve as a high impact rendering driver for this industry over the forecast period. Rising government initiatives owing to high significance towards a growth of the economy are expected to boost the biotechnology market growth over the forecast period.

Furthermore, the presence of organizations, such as the DBT, together with other government-funded institutions such as the NBTB and other autonomous organizations representing the biotechnology industry promotes funding to support R&D and product development exercises pertaining to the field and are expected to drive growth from 2013 to 2020.


Oral Presentation: Prominent speakers from the industry with prodigious experiences and Leading professionals of the industry with valuable skills. Poster presentations: Emerging researchers in the respective field, students, and post-doc fellows.
You will have a great opportunity to share your research concerns or challenges with the leading experts in the field of Biotechnology and pharmaceutical Industry.
The open panel discussion intend to have discussion involving current challenges in Biotechnology and pharma Industry in which all participants can interact with panel followed by aQ/A session.
A wide range of promotional opportunities is available to help companies boost their visibility during the Biopharma Forum 2017: Exhibition space, Event advertising, and related advertising opportunities, Exhibitors workshop

Our Speakers

Poster Presentation

Organizing Committee

Dr. S. V. Eswaran

RCB, Faridabad, India

Dr. Robert White

University of York, UK

View All

Student OCM


BITS- PILANI, Rajasthan


Chettinad Academy of Research and Education, Tamil Nadu

View All

Review Board

Dr. William Carey

Reviewer, USA

Dr. Alireza Heidari

California South University, USA

View All

Programs Programs Detail Time

Spot registrations

08:00 - 08:30 am


Dr. G. P. Talwar, Founder, and Director, National Institute of Immunology, India. Title: A Vaccine endowed with Multiple Applications and a Polyherbal formulation for Reproductive Health of Women. 09:15 am - 09:45am


Mr. Mayur Parmar, FDC, Govt. Of Gujarat Title: Pharmavision 2020 opportunities and obstacles 09:45 am - 10:10 am


Mr. Rajiv Dua, Sun Pharmaceuticals Ltd., India Title: Optimizing bio-analytical techniques and methods used for stability testing 10:10 am - 10:35 am



Dr. Ambrish Srivastava, Vice President – Medical Affairs, Alkem Laboratories Ltd., India Title: The role of Biosimilar in Indian Pharma Industry 10:50 am - 11:15 am


Dr. S. V. Eswaran, Emeritus Scientist & Emeritus Professor, RCB, Faridabad, India Title: Water Soluble Nanocarbon Materials: A Panacea for All? 11:15 am - 11:40 am


Dr. Anthony J.Clarke, Professor, University of Guelph, Canada Title: Peptidoglycan O-acetyltransferase A (OatA) as an anti-virulence target in Gram-positive pathogens: its structure, mechanism of action, and inhibition. 11:40 am - 12:05 pm


Dr. Pawan Dhar, School of Biotechnology, JNU, New Delhi Title: Presenting a new drug discovery platform 12:05 pm - 12:30 pm


Ms. Bindu Ajit, Program Director, Biocon Academy Title: Biocon Academy - addressing skill challenges in Biopharma. 12:30 pm - 12:55 pm

LUNCH BREAK 12:55 pm - 2:00 pm

SPEAKER SESSIONS 2:00 pm - 4:00 pm

SPEAKER SESSIONS 4:00 pm - 6:00 pm

DAY 1 CLOSURE 6:00 pm


Hyatt Regency Gurgaon, New Delhi


Hyatt Regency Gurgaon, New Delhi NCR NH8, Sector 83, Gurugram, Haryana 122004

Reach Us at

Clyto Access(USA)
  • 600 West Broadway Suite 700
  • San Diego CA 92101 | USA
  • : 1-619-471-1648
Clyto Access(India)
  • Novel Business Center
  • 10 BTM Layout 1 | Bengaluru,
  • Karnataka 560068 | India
  • : 91-080-41474547

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.